Search by Drug Name or NDC
NDC 23155-0023-10 Buspirone Hydrochloride 5 mg/1 Details
Buspirone Hydrochloride 5 mg/1
Buspirone Hydrochloride is a ORAL TABLET in the HUMAN PRESCRIPTION DRUG category. It is labeled and distributed by Heritage Pharmaceuticals Inc. d/b/a Avet Pharmaceuticals Inc.. The primary component is BUSPIRONE HYDROCHLORIDE.
MedlinePlus Drug Summary
Buspirone is used to treat anxiety disorders or in the short-term treatment of symptoms of anxiety. Buspirone is in a class of medications called anxiolytics. It works by changing the amounts of certain natural substances in the brain.
Related Packages: 23155-0023-10Last Updated: 11/30/2022
MedLinePlus Full Drug Details: Buspirone
Product Information
NDC | 23155-0023 |
---|---|
Product ID | 23155-023_774a9072-c089-4cbf-865f-0c88271b5e7c |
Associated GPIs | 57200005100310 |
GCN Sequence Number | 003782 |
GCN Sequence Number Description | buspirone HCl TABLET 5 MG ORAL |
HIC3 | H2F |
HIC3 Description | ANTI-ANXIETY DRUGS |
GCN | 28890 |
HICL Sequence Number | 001620 |
HICL Sequence Number Description | BUSPIRONE HCL |
Brand/Generic | Generic |
Proprietary Name | Buspirone Hydrochloride |
Proprietary Name Suffix | n/a |
Non-Proprietary Name | Buspirone Hydrochloride |
Product Type | HUMAN PRESCRIPTION DRUG |
Dosage Form | TABLET |
Route | ORAL |
Active Ingredient Strength | 5 |
Active Ingredient Units | mg/1 |
Substance Name | BUSPIRONE HYDROCHLORIDE |
Labeler Name | Heritage Pharmaceuticals Inc. d/b/a Avet Pharmaceuticals Inc. |
Pharmaceutical Class | n/a |
DEA Schedule | n/a |
Marketing Category | ANDA |
Application Number | ANDA204582 |
Listing Certified Through | 2024-12-31 |
Package
NDC 23155-0023-10 (23155002310)
NDC Package Code | 23155-023-10 |
---|---|
Billing NDC | 23155002310 |
Package | 1000 TABLET in 1 BOTTLE (23155-023-10) |
Marketing Start Date | 2018-09-20 |
NDC Exclude Flag | N |
Pricing Information | N/A |